These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


362 related items for PubMed ID: 27614009

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.
    Laizure SC, Parker RB, Herring VL, Hu ZY.
    Drug Metab Dispos; 2014 Feb; 42(2):201-6. PubMed ID: 24212379
    [Abstract] [Full Text] [Related]

  • 3. Carboxylesterase-2 plays a critical role in dabigatran etexilate active metabolite formation.
    Laizure SC, Chen F, Farrar JE, Ali D, Yang B, Parker RB.
    Drug Metab Pharmacokinet; 2022 Dec; 47():100479. PubMed ID: 36375226
    [Abstract] [Full Text] [Related]

  • 4. Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.
    Shi J, Wang X, Eyler RF, Liang Y, Liu L, Mueller BA, Zhu HJ.
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):555-561. PubMed ID: 27228223
    [Abstract] [Full Text] [Related]

  • 5. Sacubitril Is Selectively Activated by Carboxylesterase 1 (CES1) in the Liver and the Activation Is Affected by CES1 Genetic Variation.
    Shi J, Wang X, Nguyen J, Wu AH, Bleske BE, Zhu HJ.
    Drug Metab Dispos; 2016 Apr; 44(4):554-9. PubMed ID: 26817948
    [Abstract] [Full Text] [Related]

  • 6. Pharmacogenetics of dabigatran etexilate interindividual variability.
    Dimatteo C, D'Andrea G, Vecchione G, Paoletti O, Cappucci F, Tiscia GL, Buono M, Grandone E, Testa S, Margaglione M.
    Thromb Res; 2016 Aug; 144():1-5. PubMed ID: 27261537
    [Abstract] [Full Text] [Related]

  • 7. The Distribution of the Genotypes of ABCB1 and CES1 Polymorphisms in Kazakhstani Patients with Atrial Fibrillation Treated with DOAC.
    Abdrakhmanov A, Akilzhanova A, Shaimerdinova A, Zhalbinova M, Tuyakova G, Abildinova S, Albayev R, Ainabekova B, Chinybayeva A, Suleimen Z, Bekbossynova M.
    Genes (Basel); 2023 May 29; 14(6):. PubMed ID: 37372371
    [Abstract] [Full Text] [Related]

  • 8. Effect of CES1 and ABCB1 genotypes on the pharmacokinetics and clinical outcomes of dabigatran etexilate in patients with atrial fibrillation and chronic kidney disease.
    Sychev D, Skripka A, Ryzhikova K, Bochkov P, Shevchenko R, Krupenin P, Ivashchenko D, Kogay V, Listratov A, Krainyaya A, Gurinovich O, Sokolova A, Napalkov D, Fomin V.
    Drug Metab Pers Ther; 2020 Mar 05; 35(1):. PubMed ID: 32134727
    [Abstract] [Full Text] [Related]

  • 9. Impact of carboxylesterase 1 genetic polymorphism on trandolapril activation in human liver and the pharmacokinetics and pharmacodynamics in healthy volunteers.
    Wang X, Her L, Xiao J, Shi J, Wu AH, Bleske BE, Zhu HJ.
    Clin Transl Sci; 2021 Jul 05; 14(4):1380-1389. PubMed ID: 33660934
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism.
    Hu ZY, Parker RB, Herring VL, Laizure SC.
    Anal Bioanal Chem; 2013 Feb 05; 405(5):1695-704. PubMed ID: 23239178
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation.
    Zhu HJ, Wang X, Gawronski BE, Brinda BJ, Angiolillo DJ, Markowitz JS.
    J Pharmacol Exp Ther; 2013 Mar 05; 344(3):665-72. PubMed ID: 23275066
    [Abstract] [Full Text] [Related]

  • 16. Carboxylesterase 1 and Precision Pharmacotherapy: Pharmacogenetics and Nongenetic Regulators.
    Her L, Zhu HJ.
    Drug Metab Dispos; 2020 Mar 05; 48(3):230-244. PubMed ID: 31871135
    [Abstract] [Full Text] [Related]

  • 17. Contributions of Cathepsin A and Carboxylesterase 1 to the Hydrolysis of Tenofovir Alafenamide in the Human Liver, and the Effect of CES1 Genetic Variation on Tenofovir Alafenamide Hydrolysis.
    Li J, Shi J, Xiao J, Tran L, Wang X, Zhu HJ.
    Drug Metab Dispos; 2022 Mar 05; 50(3):243-248. PubMed ID: 34933885
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.